[Single-center clinical study of upadacitinib in children with refractory inflammatory bowel disease].

Cheng Q, Fang YH, Yu JD, Chen J, Xu LJ, Luo YY.

Open source

DOI
10.7499/j.issn.1008-8830.2509011
Published
2026-05-01
Container
Zhongguo Dang Dai Er Ke Za Zhi
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7499/j.issn.1008-8830.2509011,
  title = {[Single-center clinical study of upadacitinib in children with refractory inflammatory bowel disease].},
  author = {Cheng Q and  Fang YH and  Yu JD and  Chen J and  Xu LJ and  Luo YY.},
  year = {2026},
  journal = {Zhongguo Dang Dai Er Ke Za Zhi},
  doi = {10.7499/j.issn.1008-8830.2509011},
  url = {https://doi.org/10.7499/j.issn.1008-8830.2509011}
}

RIS

TY  - JOUR
TI  - [Single-center clinical study of upadacitinib in children with refractory inflammatory bowel disease].
AU  - Cheng Q
AU  -  Fang YH
AU  -  Yu JD
AU  -  Chen J
AU  -  Xu LJ
AU  -  Luo YY.
PY  - 2026
JO  - Zhongguo Dang Dai Er Ke Za Zhi
DO  - 10.7499/j.issn.1008-8830.2509011
UR  - https://doi.org/10.7499/j.issn.1008-8830.2509011
ER  - 

APA

Q, C., YH, F., JD, Y., J, C., LJ, X., & YY., L. (2026). [Single-center clinical study of upadacitinib in children with refractory inflammatory bowel disease].. Zhongguo Dang Dai Er Ke Za Zhi. https://doi.org/10.7499/j.issn.1008-8830.2509011

Source records